NMTCNEUROONE MEDICAL TECHNOLOGIES Corp同业对比
NEUROONE MEDICAL TECHNOLOGIES Corp 与Surgical & Medical Instruments & Apparatus的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Surgical & Medical Instruments & Apparatus)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NMTC本股 | $13M#7 | — | 3.3x#9 | 1.4x#6 | 163.5%#2 | 70.7%#2 | -46.5%#4 | -95.7%#4 | -229.5%#5 | — | -74.3%#11 | — |
| BEAT | $24M#1 | — | 2.9x#8 | — | — | -8.1%#10 | — | -257.0%#7 | — | — | -70.4%#8 | — |
| FEMY | $21M#2 | 0.4x#4 | 5.3x#11 | 9.3x#8 | 40.8%#3 | 1.0%#8 | -767.0%#8 | -462.1%#11 | — | — | -64.1%#7 | — |
| RVP | $21M#3 | — | 0.3x#1 | 0.6x#2 | 15.8%#6 | -5.7%#9 | -55.3%#5 | -17.2%#2 | -29.7%#1 | 5#1 | -13.3%#1 | — |
| CNSY | $16M#4 | 0.2x#2 | 2.8x#7 | 3.0x#7 | -10.5%#7 | -72.5%#13 | -293.5%#7 | -409.8%#10 | -146.1%#3 | 4#3 | -80.8%#12 | — |
| ICU | $15M#5 | — | 3.6x#10 | 12.5x#10 | 814.1%#1 | 51.1%#3 | -986.6%#9 | -282.8%#9 | -252.7%#6 | 5#1 | -61.1%#6 | — |
| AEMD | $4M#15 | 0.2x#3 | 0.8x#3 | — | -100.0%#12 | 46.6%#5 | — | -137.5%#5 | — | — | -98.4%#14 | — |
| MDAIW | $14M#6 | — | — | 0.7x#5 | -33.6%#8 | 50.1%#4 | -43.8%#3 | — | — | 3#4 | -18.2%#2 | — |
| ADGM | $11M#8 | — | — | — | — | — | — | — | -131.2%#2 | — | -71.9%#10 | — |
| SINT | $11M#9 | — | 2.3x#6 | 10.9x#9 | -64.7%#10 | 6.0%#7 | -1053.1%#10 | -214.6%#6 | -852.2%#7 | 3#4 | -57.9%#5 | — |
| ALUR | $10M#10 | — | — | 0.7x#4 | -52.6%#9 | -299.5%#15 | -198.0%#6 | — | — | 2#6 | -97.9%#13 | — |
| BTCY | $10M#11 | — | — | 0.6x#3 | 16.0%#5 | 71.5%#1 | 10.6%#1 | — | — | — | -31.2%#3 | — |
| PFSA | $1M#16 | 0.0x#1 | — | 12.6x#11 | — | -288.1%#14 | -27706.0%#11 | — | — | — | — | — |
| BEATW | $7M#12 | — | 0.9x#4 | — | — | -8.1%#10 | — | -257.0%#7 | — | — | -41.1%#4 | — |
| NVNO | $6M#13 | — | 0.3x#2 | 198.0x#12 | -83.3%#11 | 10.8%#6 | -66891.8%#12 | -94.2%#3 | — | — | -71.3%#9 | — |
| SNOA | $6M#14 | — | 0.9x#5 | 0.3x#1 | 36.7%#4 | -8.2%#12 | -12.6%#2 | 0.0%#1 | -174.4%#4 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-18。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议